These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9057740)
41. Problems with interpreting the data in Kassler-Taub et al's article comparing irbesartan and losartan. Bunt T Am J Hypertens; 1999 Jan; 12(1 Pt 1):79-81. PubMed ID: 10075390 [No Abstract] [Full Text] [Related]
42. A new class of antihypertensive therapy: angiotensin II receptor antagonists. Ellis ML; Patterson JH Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079 [TBL] [Abstract][Full Text] [Related]
43. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823 [TBL] [Abstract][Full Text] [Related]
44. A risk-benefit assessment of losartan potassium in the treatment of hypertension. Burrell LM Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643 [TBL] [Abstract][Full Text] [Related]
45. [Angiotensin receptor antagonists. A new class of antihypertensive agents]. Mann J Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827 [No Abstract] [Full Text] [Related]
46. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837 [TBL] [Abstract][Full Text] [Related]
47. [Angiotensin II antagonists]. Tikkanen I; Tikkanen T Duodecim; 1995; 111(18):1733-5. PubMed ID: 9340266 [No Abstract] [Full Text] [Related]
48. Effect of chronic losartan potassium treatment on fructose-induced hypertension. Iyer SN; Katovich MJ Life Sci; 1994; 55(7):PL139-44. PubMed ID: 8041226 [TBL] [Abstract][Full Text] [Related]
49. Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required? Morrell NW Chest; 1997 May; 111(5):1469-70. PubMed ID: 9149625 [No Abstract] [Full Text] [Related]
50. New angiotensin-II blocker. Lilley LL; Guanci R Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540 [No Abstract] [Full Text] [Related]
51. Angiotensin II receptor antagonists: the prototype losartan. Schaefer KL; Porter JA Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950 [TBL] [Abstract][Full Text] [Related]
52. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Bunt T Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426 [No Abstract] [Full Text] [Related]